Navigation Links
CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
Date:4/20/2012

WOONSOCKET, R.I., April 20, 2012 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) will be holding a conference call on Wednesday, May 2, 2012, at 8:30 a.m. (EDT) with analysts and investors to discuss its first quarter 2012 financial results.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark website for all interested parties.  To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the web site for a one-year period following the conference call.

About the Company

CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are a pharmacy innovation company, uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com/.


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Ranks Among Top 25 Most Reputable Companies in America on Forbes List
2. CVS Caremark Corporation Announces Quarterly Dividend
3. CVS Caremarks Chief Medical Officer Troyen Brennan is Named to the National Commission on Physician Payment Reform
4. CVS Caremarks MinuteClinic to Deploy Allscripts EHR Nationally
5. CVS Caremark to Present at the RBC Healthcare Conference
6. Report: CVS Caremark Contributes Billions to Rhode Island Economy
7. NCPA Comments on FTC Action Against CVS Caremark, Vows to Continue PBM Transparency Efforts
8. FTC Ends Investigation of CVS Caremark
9. CVS Caremark Corporation Settles FTC Deceptive Pricing Charges
10. CVS Caremark Study Finds Integrated Pharmacy-Based Program Improved Diabetes Medication Initiation and Adherence Rates
11. CVS Caremark Outlines Strong Growth for 2012 and Confirms 2011 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/13/2017)... --  OrthoAtlanta has been named the official orthopedic and ... for the 2018 College Football Playoff (CFP) National Championship to ... in Atlanta, Georgia . OrthoAtlanta is proud ... participating in many activities leading up to, and including the ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):